Financhill
Back

Freeport-McMoRan, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Buy
74

FCX
Freeport-McMoRan, Inc.

Last Price:
$47.86
Seasonality Move:
5.27%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.66
Seasonality Move:
11.58%
Buy
74
Freeport-McMoRan, Inc. (FCX) is a Buy

Is Freeport-McMoRan, Inc. a Buy, Sell or Hold?

  • The current Freeport-McMoRan, Inc. [FCX] share price is $47.38. The Score for FCX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • FCX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCX Stock Price Chart

What is Freeport-McMoRan, Inc.'s stock price today?

  • The Freeport-McMoRan, Inc. share price today is $47.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.58 Buy
Relative Strength Index (14 RSI): 69.38 Buy
Chaikin Money Flow: -8167402 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.99 - 45.07) Buy
Bollinger Bands (100): (39.75 - 44.73) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.76 Buy
20-day SMA: 42.95 Buy
50-day SMA: 41.89 Buy
200-day SMA: 40.75 Buy
8-day EMA: 45.81 Buy
20-day EMA: 43.91 Buy
50-day EMA: 42.6 Buy
200-day EMA: 41.77 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Freeport-McMoRan, Inc. Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.63 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Freeport-McMoRan, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):